← Back to Search

Stress Impact for Rosacea

N/A
Recruiting
Led By Kristen Metzler-Wilson, PT, PhD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediate (during the single-day study). this study consists of a one-day protocol, during which this outcome is measured.
Awards & highlights

Study Summary

This trial seeks to understand how stress can trigger rosacea symptoms to inform treatments for the 16 million Americans it affects.

Who is the study for?
This trial is for healthy males and females with mild to moderate rosacea, who are not pregnant or breastfeeding. Participants should not have any major health issues like heart or neurological disorders, no recent drug/alcohol abuse, no allergies to protocol drugs, non-smokers, and a BMI under 35.Check my eligibility
What is being tested?
The study investigates how stressors affecting the 'fight or flight' nervous system contribute to rosacea symptoms. It aims to improve understanding of this relationship in order to develop better treatments for those suffering from rosacea.See study design
What are the potential side effects?
Since the trial involves studying the effects of systemic and local stressors on individuals with rosacea rather than testing new medications, specific side effects are not listed but may include temporary increased redness or inflammation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate (during the single-day study). this study consists of a one-day protocol, during which this outcome is measured.
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediate (during the single-day study). this study consists of a one-day protocol, during which this outcome is measured. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Skin blood flow
Skin sympathetic nerve activity

Trial Design

1Treatment groups
Experimental Treatment
Group I: Autonomic responses to stressorsExperimental Treatment1 Intervention
Protocol 1: mental math and handgrip exercise. Protocol 2: systemic stressors and end-organ receptor stimulation. Protocol 3: local heating.

Find a Location

Who is running the clinical trial?

Marian UniversityOTHER
Indiana UniversityLead Sponsor
993 Previous Clinical Trials
1,095,073 Total Patients Enrolled
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
485 Previous Clinical Trials
1,086,671 Total Patients Enrolled
~3 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top